Antibody blockade of mucosal addressin cell adhesion molecule-1 attenuates proinflammatory activity of mesenteric lymph after hemorrhagic shock and resuscitation

被引:4
|
作者
Zhang, Hong-yi [1 ,2 ,3 ]
Besner, Gail E. [4 ,5 ]
Feng, Jie-xiong [1 ,2 ,3 ]
机构
[1] Tongji Hosp, Dept Pediat Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China
[2] Tongji Med Coll, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Wuhan 430074, Peoples R China
[4] Nationwide Childrens Hosp, Res Inst, Dept Pediat Surg, Ctr Perinatal Res, Columbus, OH USA
[5] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
基金
中国国家自然科学基金;
关键词
INTESTINAL ISCHEMIA-REPERFUSION; GUT BARRIER FUNCTION; T-LYMPHOCYTES; GROWTH-FACTOR; CHRONIC INFLAMMATION; LUNG INJURY; MADCAM-1; MICE; IMMUNITY; TRAUMA;
D O I
10.1016/j.surg.2015.12.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The current study was designed to determine the effects of antibody blockade of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) on the proinflammatory activity of mesenteric lymph after hemorrhagic shock and resuscitation (HS/R). Methods. Rats were subjected to HS/R with or without treatment with MAdCAM-1 polyclonal antibody. MAdCAM-1 expression and lymphocyte infiltration in rats were examined. Post-shock mesenteric lymph was collected, filtered to remove lymphocytes, and transfused into recipient mice to induce systemic inflammation and intestinal injury. The proinflammatory activity of post-shock lymph in mice was determined by examining intestinal permeability, enterocyte apoptosis, intestinal lactate levels, lung myeloperoxidase (MPO) activity, and serum cytokine levels. Survival of recipient mice was determined over a 1-week time period. Results. Rats subjected to HS/R had increased MAdCAM-1 expression and lymphocyte infiltration in the intestine. Antibody blockade of MAdCAM-1 attenuated the increased lymphocyte infiltration after HS/R (P < .05). Post-shock mesenteric lymph transfusion significantly increased mortality accompanied by increases in gut permeability, enterocyte apoptosis, intestinal lactate levels, lung MPO activity, and serum levels of interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha, IL-10, and transforming growth factor-beta (all P < .05). Antibody blockade of MAdCAM-1 in rats subjected to HS/R attenuated the proinflammatory activity of post-shock mesenteric lymph, with abrogation of lymph transfusion induced increases in mortality, gut permeability, epithelial cell apoptosis, intestinal lactate levels, lung MPO activity, and serum levels of IL-1 beta, IL-6, and TNF-alpha (all P < .05). Conclusion. These findings demonstrate that antibody blockade of MAdCAM-1 attenuates the proinflammatory activity of mesenteric lymph after HS/R..
引用
收藏
页码:1449 / 1460
页数:12
相关论文
共 50 条
  • [41] ORGANIZATION, REGULATORY SEQUENCES, AND ALTERNATIVELY SPLICED TRANSCRIPTS OF THE MUCOSAL ADDRESSIN CELL-ADHESION MOLECULE-1 (MADCAM-1) GENE
    SAMPAIO, SO
    LI, X
    TAKEUCHI, M
    MEI, C
    FRANCKE, U
    BUTCHER, EC
    BRISKIN, MJ
    JOURNAL OF IMMUNOLOGY, 1995, 155 (05): : 2477 - 2486
  • [42] Mucosal addressin cell adhesion molecule-1 (MAdCAM-1)Its binding motif for α4β7 and role in experimental colitis
    Sherman Fong
    Susan Jones
    Mark E. Renz
    Henry H. Chiu
    Anne M. Ryan
    Leonard G. Presta
    David Jackson
    Immunologic Research, 1997, 16 : 299 - 311
  • [43] Regulation of Mucosal Addressin Cell Adhesion Molecule 1 Expression in Human and Mice by Vascular Adhesion Protein 1 Amine Oxidase Activity
    Liaskou, Evaggelia
    Karikoski, Marika
    Reynolds, Gary M.
    Lalor, Patricia F.
    Weston, Chris J.
    Pullen, Nick
    Salmi, Marko
    Jalkanen, Sirpa
    Adams, David H.
    HEPATOLOGY, 2011, 53 (02) : 661 - 672
  • [44] Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression
    Kanwar, JR
    Kanwar, RK
    Wang, DM
    Krissansen, GW
    IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (06): : 641 - 645
  • [45] Expression of mucosal addressin cell adhesion molecule-1 on the reticular framework between white pulp and the marginal zone in the human spleen
    Satoh, Takashi
    Oikawa, Hiroki
    Yashima-Abo, Akiko
    Nishiya, Masao
    Masuda, Tomoyuki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2019, 59 (04) : 187 - 195
  • [46] Involvement of beta(7) integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in nonobese diabetic mice
    Yang, XD
    Sytwu, HK
    McDevitt, HO
    Michie, SA
    DIABETES, 1997, 46 (10) : 1542 - 1547
  • [47] Synthesis and structure -: Activity relationship of mannose-based peptidomimetics selectively blocking integrin α4β7 binding to mucosal addressin cell adhesion molecule-1
    Locardi, E
    Boer, J
    Modlinger, A
    Schuster, A
    Holzmann, B
    Kessler, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (26) : 5752 - 5762
  • [48] Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease
    Vermeire, Severine
    Danese, Silvio
    Sandborn, William J.
    Schreiber, Stefan
    Hanauer, Stephen
    D'Haens, Geert
    Nagy, Peter
    Thakur, Manoj
    Bliss, Caleb
    Cataldi, Fabio
    Goetsch, Martina
    Gorelick, Kenneth J.
    Reinisch, Walter
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 708 - 719
  • [49] Validation of assay for detection of free soluble mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in human serum and cerebrospinal fluid
    Ocana, M. Fernandez
    Zhang, J. Y.
    Jones, B. R.
    Martin, S. W.
    Goetsch, M.
    Neubert, H.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S119 - S119
  • [50] Increased expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and lymphocyte recruitment in murine gastritis induced by Helicobacter pylori
    Hatanaka, K
    Hokari, R
    Matsuzaki, K
    Kato, S
    Kawaguchi, A
    Nagao, S
    Suzuki, H
    Miyazaki, K
    Sekizuka, E
    Nagata, H
    Ishii, H
    Miura, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (02): : 183 - 189